PTLA

Portola Pharmaceuticals, Inc.

PTLA

Delisted

PTLA was delisted on the 1st of July, 2020.

215 hedge funds and large institutions have $2.82B invested in Portola Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 93 increasing their positions, 55 reducing their positions, and 37 closing their positions.

2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3 2013 Q2

Holders

215

Holders Change

-6

Holders Change %

-2.71%

% of All Funds

4.88%

Holding in Top 10

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

0.14%

New

Increased

Reduced

Closed

Calls

$18.7M

Puts

$41.4M

Net Calls

-$22.7M

Net Calls Change

-$8.93M

Top Buyers

1	PHS 1 PFM Health Sciences San Francisco, California	$289M
2	2 Wells Fargo San Francisco, California	$33.4M
3	3 Wellington Management Group Boston, Massachusetts	$292M
4	CCM 4 Cadian Capital Management New York	$74.2M
5	5 BlackRock New York	$229M

Top Sellers

1	1 Fidelity Investments Boston, Massachusetts	$207M
2	2 Citadel Advisors Miami, Florida	$1.28M
3	CAM 3 Cormorant Asset Management Boston, Massachusetts	$0
4	LCM 4 Laurion Capital Management New York	$0
5	5 Millennium Management New York	$501K

#	Name	Market Value	Shares	Shares Change	Shares Change %
1	1 Wellington Management Group Boston, Massachusetts	$292M	5,993,528	+530,581	+10%
2	PHS 2 PFM Health Sciences San Francisco, California	$289M	5,941,055	+862,909	+17%
3	3 Vanguard Group Malvern, Pennsylvania	$262M	5,388,190	+145,874	+3%
4	4 Temasek Holdings Singapore	$238M	4,883,568	–	–
5	5 BlackRock New York	$229M	4,696,591	+293,802	+7%
6	6 Fidelity Investments Boston, Massachusetts	$207M	4,245,246	-1,515,210	-26%
7	7 State Street Boston, Massachusetts	$111M	2,288,721	-112,284	-5%
8	CCM 8 Cadian Capital Management New York	$74.2M	1,524,443	+357,700	+31%
9	9 D.E. Shaw & Co New York	$50.3M	1,032,577	+2,555	+0.2%
10	KCM 10 Kornitzer Capital Management Shawnee Mission, Kansas	$40.2M	826,027	+98,215	+13%
11	ZCI 11 Zevenbergen Capital Investments Edmonds, Washington	$37.3M	765,475	+187,910	+33%
12	FAM 12 Fred Alger Management New York	$36.8M	756,425	+32,694	+5%
13	13 Northern Trust Chicago, Illinois	$35.7M	734,070	+46,085	+7%
14	PAMU 14 Pictet Asset Management (UK) London, United Kingdom	$34.6M	710,734	+232,044	+48%
15	15 Norges Bank Oslo, Norway	$33.8M	694,537	–	–
16	16 Wells Fargo San Francisco, California	$33.4M	686,816	+640,023	+1,368%
17	17 JPMorgan Chase & Co New York	$31.7M	650,264	-94,438	-13%
18	18 Deutsche Bank Frankfurt Am Main Ge, Germany	$30.7M	631,007	+18,012	+3%
19	19 Geode Capital Management Boston, Massachusetts	$30.2M	620,913	+44,612	+8%
20	PC 20 Polar Capital London, United Kingdom	$28.6M	588,200	–	–
21	EA 21 Emerald Advisers Leola, Pennsylvania	$26.3M	540,661	+86,740	+19%
22	SAM 22 Sectoral Asset Management Montreal, Quebec, Canada	$26.1M	536,414	+30,000	+6%
23	23 Susquehanna International Group Bala Cynwyd, Pennsylvania	$23.9M	491,020	+214,814	+78%
24	PA 24 Pinnacle Associates New York	$21.6M	444,676	-47,705	-10%
25	HCMT 25 Highland Capital Management (Texas) Dallas, Texas	$21.6M	444,513	+42,390	+11%

Portola Pharmaceuticals, Inc. PTLA

Top Buyers

Top Sellers

Portola Pharmaceuticals, Inc.

PTLA